Novel antimicrobial and anticancer drugs from bacteria

What is it about?

Microbes such as bacteria and fungi are promising sources for structurally diverse and potent bioactive compounds. The strong impact of classical natural compounds with advanced microbial genetics and bioinformatics will help to overcome supply and sustainability issues from the past and to promote bioactive substances from microbial species. Actinomycetes are mostly responsible for the production of half of the discovered secondary metabolites, such as antibiotics, antitumor agents, immunosuppressive agents, and enzymes. The studies on metabolism of aromatic amino acids in microorganisms show that they evolved secondary metabolic pathways with the capacity to produce compounds displaying an effective array of pharmacological applications. The natural compounds show a wide range of biological activities such as antimicrobial, anticancer, antialgal, and antiperonosporomycetal.

Featured Image

Why is it important?

biological activities such as antimicrobial, anticancer, antialgal, and antiperonosporomycetal.

Perspectives